Inactive Instrument

ProUroCare Medical Inc. Stock price Other OTC

Equities

PUMD

US74373C2061

Advanced Medical Equipment & Technology

Sales 2011 - Sales 2012 - Capitalization 14.36M
Net income 2011 -2M Net income 2012 -2M EV / Sales 2011 -
Net Debt 2011 1.91M Net Debt 2012 2.13M EV / Sales 2012 -
P/E ratio 2011
-7.97 x
P/E ratio 2012
-4.81 x
Employees -
Yield 2011 *
-
Yield 2012
-
Free-Float 98.98%
More Fundamentals * Assessed data
Dynamic Chart
ProUroCare Medical Inc. (ProUroCare) is engaged in the business of developing products for the detection and characterization of prostate disease. The Company is focused on its product, prostate mechanical imaging device called the ProUroScan System. The ProUroScan is an imaging system that is designed to produce an elasticity image of the prostate as an adjunctive aid in visualizing and documenting abnormalities of the prostate that have been detected by a digital rectal examination (DRE). The ProUroScan uses an array of sensors mounted on a rectal probe, a central processing unit, and software and image construction algorithms to provide a real time color image of abnormalities in the prostate. In addition, it provides mechanical or elasticity imaging, which refers to a non-invasive analysis of tissue movement and displacement. The Company's product also provides two-and three-dimensional prostate images.
More about the company
  1. Stock
  2. Equities
  3. Stock ProUroCare Medical Inc.
  4. Stock ProUroCare Medical Inc. - Other OTC